Figures & data
Figure 1 Simple reaction time test results in the study and control groups.
![Figure 1 Simple reaction time test results in the study and control groups.](/cms/asset/f0bacbd3-c520-4801-b6cd-4ec78688de8c/dndt_a_200501_f0001_c.jpg)
Figure 2 VMT and VMDT results in the study and control groups.
![Figure 2 VMT and VMDT results in the study and control groups.](/cms/asset/41e0409f-5b4a-446f-ad4f-840c034825b1/dndt_a_200501_f0002_c.jpg)
Figure 3 GoNoGo test results in the study and control groups.
![Figure 3 GoNoGo test results in the study and control groups.](/cms/asset/7ba2790d-740d-48aa-a33a-53b94fa36196/dndt_a_200501_f0003_c.jpg)
Figure 4 VWMT results in the study and control groups.
![Figure 4 VWMT results in the study and control groups.](/cms/asset/ea895e55-ed3b-4a19-9271-ec906cea3be1/dndt_a_200501_f0004_c.jpg)
Table 1 Demographic and clinical data of the two prostate cancer therapy subgroups
Table 2 Psychological, clinical, and biochemical parameters in prostate cancer therapy subgroups
Table 3 Cognitive test results for the prostate cancer therapy subgroups
Table 4 R-Spearman correlations between cognitive test results and erectile function before and after surgery in all groups (n=100)
Table 5 R-Spearman correlations between demographic, clinical, psychological, and biochemical factors and erectile function before and after surgery in all groups (n=100)
Table 6 R-Spearman correlations between clinical scales and cognitive test results